Bank of America’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-89,304
| Closed | -$271K | – | 7181 |
|
|
2023
Q4 | $271K | Buy |
89,304
+8,830
| +11% | +$26.8K | ﹤0.01% | 5001 |
|
|
2023
Q3 | $229K | Hold |
80,474
| – | – | ﹤0.01% | 4977 |
|
|
2023
Q2 | $209K | Buy |
80,474
+12,935
| +19% | +$33.6K | ﹤0.01% | 4974 |
|
|
2023
Q1 | $123K | Buy |
67,539
+42,722
| +172% | +$77.8K | ﹤0.01% | 5379 |
|
|
2022
Q4 | $40.9K | Buy |
24,817
+3,810
| +18% | +$6.29K | ﹤0.01% | 5761 |
|
|
2022
Q3 | $40K | Sell |
21,007
-5,361
| -20% | -$10.2K | ﹤0.01% | 5926 |
|
|
2022
Q2 | $79K | Buy |
26,368
+2,138
| +9% | +$6.41K | ﹤0.01% | 5814 |
|
|
2022
Q1 | $92K | Buy |
24,230
+8,886
| +58% | +$33.7K | ﹤0.01% | 6129 |
|
|
2021
Q4 | $175K | Buy |
15,344
+3,016
| +24% | +$34.4K | ﹤0.01% | 5763 |
|
|
2021
Q3 | $216K | Buy |
12,328
+12,318
| +123,180% | +$216K | ﹤0.01% | 5420 |
|
|
2021
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 7243 |
|